The Centers for Medicare & Medicaid Services (CMS) has finalized 2026 payment amounts for the FSYX Ocular Pressure Adjusting ...

SAN FRANCISCO, July 21, 2025 /PRNewswire/ -- The Glaucoma Center of San Francisco is excited to announce the first treatment of a patient in the U.S. with the non-invasive Eyetronic nerve stimulating ...

Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years. Neil Minkoff, MD: Where do we see glaucoma therapy going in the next 24 to 36 months, due to ...

Glaucoma is a neurodegenerative eye disease defined by the progressive death of nerve cells in the retina called retinal ...

Medications are still the most widespread first-line treatment option for glaucoma, but recent years have seen a growing ...

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the ...

Glaucoma causes vision loss by damaging the optic nerve. This leads to loss of peripheral vision and eventually blindness. The damage to the optic nerve is multifactorial, but increased ocular ...

A Green Bay ophthalmologist is traveling the world to train doctors in glaucoma treatment, a leading cause of irreversible ...

Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

One of the most popular drugs in the world can potentially do a number on your eyesight, new research suggests. Scientists in ...

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the ...